All Relations between Schizophrenia and Atypical antipsychotics

Publication Sentence Publish Date Extraction Date Species
Dominic Pilon, Tony B Amos, Rhiannon Kamstra, Ameur M Manceur, Antoine C El Khoury, Patrick Lefebvr. Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis. Current medical research and opinion. vol 35. issue 1. 2020-04-27. PMID:30106313. short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis. 2020-04-27 2023-08-13 Not clear
Xinyu Fang, Lixian Chen, Dandan Wang, Lingfang Yu, Yewei Wang, Yan Chen, Juanjuan Ren, Wei Tang, Chen Zhan. Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia. Psychiatry research. vol 281. 2020-04-15. PMID:31521045. this study aimed to explore the relationship between serum levels of cardiometabolic biomarkers and depressive symptoms in schizophrenia patients treated with atypical antipsychotics. 2020-04-15 2023-08-13 human
Xue Song, Antoine C El Khoury, Matthew Brouillette, David Smith, Kruti Josh. Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. Journal of medical economics. vol 22. issue 11. 2020-03-09. PMID:31062998. treatment discontinuation of long-acting injectables or oral atypical antipsychotics among medicaid recipients with schizophrenia. 2020-03-09 2023-08-13 Not clear
Lavanya P Sharma, Y C Janardhan Redd. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder. Indian journal of psychiatry. vol 61. issue Suppl 1. 2020-02-25. PMID:30745688. in addition, certain atypical antipsychotics, clozapine in particular are known to induce or worsen ocs in schizophrenia. 2020-02-25 2023-08-13 Not clear
Man Li, Weiwen Wang, Lan Sun, Wei Du, Hao Zhou, Feng Sha. Chronic clozapine treatment improves the alterations of prepulse inhibition and BDNF mRNA expression in the medial prefrontal cortex that are induced by adolescent social isolation. Behavioural pharmacology. vol 30. issue 4. 2020-02-13. PMID:30157036. clozapine, one of the atypical antipsychotics, is widely used in the treatment of schizophrenia patients and in experimental studies. 2020-02-13 2023-08-13 rat
Yasushi Yabuki, Lei Wu, Kohji Fukunag. Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway. Journal of pharmacological sciences. vol 140. issue 3. 2020-02-13. PMID:31474557. atypical antipsychotics improve positive and negative symptoms but are not effective for treating cognitive impairments in patients with schizophrenia. 2020-02-13 2023-08-13 rat
Yi Hang Tay, Jimmy Le. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia. Asian journal of psychiatry. vol 43. 2020-02-11. PMID:31059867. we hypothesized that serum adiponectin levels are similar in schizophrenia patients and controls, but decreased amongst patients on atypical antipsychotics. 2020-02-11 2023-08-13 Not clear
Antoine C El Khoury, Dominic Pilon, Laura Morrison, Nina Shak, Maude Vermette-Laforme, Tony B Amos, Edward Kim, Patrick Lefebvr. The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia. Current medical research and opinion. vol 35. issue 3. 2020-02-04. PMID:30526125. the prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in medicaid patients with schizophrenia. 2020-02-04 2023-08-13 Not clear
Antoine C El Khoury, Dominic Pilon, Laura Morrison, Nina Shak, Maude Vermette-Laforme, Tony B Amos, Edward Kim, Patrick Lefebvr. The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia. Current medical research and opinion. vol 35. issue 3. 2020-02-04. PMID:30526125. yet, only about 12% of medicaid patients with schizophrenia initiate sga-lais, with poor adherence contributing to frequent relapse among patients on oral atypical antipsychotics (oaas). 2020-02-04 2023-08-13 Not clear
Raja Lope Adam, Hatta Sidi, Marhani Midin, Hazli Zakaria, Srijit Das, Khairi Che Ma. The Role of Atypical Antipsychotics in Sexuality: Road to Recovery in Schizophrenia. Current drug targets. vol 19. issue 12. 2019-12-13. PMID:28464773. the role of atypical antipsychotics in sexuality: road to recovery in schizophrenia. 2019-12-13 2023-08-13 human
Richard G Frank, Ernst R Berndt, Alisa B Busch, Anthony F Lehma. QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY* The Quarterly review of economics and finance : journal of the Midwest Economics Association. vol 44. issue 3. 2019-11-20. PMID:17710196. the composition of treatments for schizophrenia has changed substantially over this six-year time period, toward more intensive use of atypical antipsychotics, and away from psychosocial treatments. 2019-11-20 2023-08-12 Not clear
Francesco Franza, Gabriella Carpentieri, Serena De Guglielmo, Vincenzo Fasano, Nicoletta Fiorentino, Mariangela Perito, Barbara Solomita, Gianfranco Del Buon. Neurocognitive management of the primary negative symptoms of schizophrenia: a role of atypical antipsychotics. Psychiatria Danubina. vol 28. issue Suppl-1. 2019-11-20. PMID:27663826. neurocognitive management of the primary negative symptoms of schizophrenia: a role of atypical antipsychotics. 2019-11-20 2023-08-13 Not clear
Julio Bobes, J Rejas, M Garcia-Garcia, F Rico-Villademoros, M P García-Portilla, M Madrigal, G Hernánde. Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol : Results of the EIRE Study. Clinical drug investigation. vol 22. issue 9. 2019-11-20. PMID:29492855. the eire (estudio de investigaciön de resultados en esquizofrenia - outcomes research study in schizophrenia) study was initiated in order to assess the frequency of adverse reactions [extrapyramidal symptoms (eps), hyperprolactinaemia, sexual dysfunction and weight gain] caused by atypical antipsychotics and haloperidol in patients with schizophrenia during routine treatment in clinical practice. 2019-11-20 2023-08-13 Not clear
Bo-Ra-Mi Kim, Tae-Jin Lee, Hye-Jae Lee, Bo-Hyun Park, Bong-Min Yan. Cost-Effectiveness of Sertindole among Atypical Antipsychotics in the Treatment of Schizophrenia in South Korea. Value in health regional issues. vol 1. issue 1. 2019-11-20. PMID:29702828. cost-effectiveness of sertindole among atypical antipsychotics in the treatment of schizophrenia in south korea. 2019-11-20 2023-08-13 Not clear
Bo-Ra-Mi Kim, Tae-Jin Lee, Hye-Jae Lee, Bo-Hyun Park, Bong-Min Yan. Cost-Effectiveness of Sertindole among Atypical Antipsychotics in the Treatment of Schizophrenia in South Korea. Value in health regional issues. vol 1. issue 1. 2019-11-20. PMID:29702828. this study assessed the cost-effectiveness of sertindole compared with existing atypical antipsychotics in the treatment of patients with schizophrenia in the south korean setting. 2019-11-20 2023-08-13 Not clear
Vlado Jukic, Miro Jakovljevic, Igor Filipcic, Miroslav Herceg, Ante Silic, Tatjana Tomljanovic, Roman Zilbershtein, Rasmus C D Jensen, Michiel E H Hemels, Thomas R Einarso. Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia. Value in health regional issues. vol 2. issue 2. 2019-11-20. PMID:29702863. cost-utility analysis of depot atypical antipsychotics for chronic schizophrenia in croatia. 2019-11-20 2023-08-13 Not clear
Yanling Zhou, Guannan Li, Dan Li, Hongmei Cui, Yuping Nin. Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study. Journal of psychopharmacology (Oxford, England). vol 32. issue 5. 2019-11-04. PMID:29493377. the long-term effects of dose reduction of atypical antipsychotics on cognitive function and symptomatology in stable patients with schizophrenia remain unclear. 2019-11-04 2023-08-13 Not clear
Rhiannon Kamstra, Dominic Pilon, Patrick Lefebvre, Bruno Emond, Kruti Josh. Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics. Current medical research and opinion. vol 34. issue 8. 2019-10-21. PMID:29452492. treatment patterns and medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics. 2019-10-21 2023-08-13 Not clear
Rhiannon Kamstra, Dominic Pilon, Patrick Lefebvre, Bruno Emond, Kruti Josh. Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics. Current medical research and opinion. vol 34. issue 8. 2019-10-21. PMID:29452492. to compare treatment patterns and medicaid spending between schizophrenia patients initiating once-monthly paliperidone palmitate (pp1m) and oral atypical antipsychotics (oaas) within four comorbid populations: cardiovascular disease (cvd), diabetes, hypertension and obesity. 2019-10-21 2023-08-13 Not clear
Wallace Breno Barbosa, Juliana de Oliveira Costa, Lívia Lovato Pires de Lemos, Rosângela Maria Gomes, Helian Nunes de Oliveira, Cristina Mariano Ruas, Francisco de Assis Acurcio, Corrado Barbui, Marion Bennie, Brian Godman, Augusto Afonso Guerr. Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil. Applied health economics and health policy. vol 16. issue 5. 2019-10-08. PMID:30051254. costs in the treatment of schizophrenia in adults receiving atypical antipsychotics: an 11-year cohort in brazil. 2019-10-08 2023-08-13 Not clear